FDA inspection
BIOCON PHARMA LIMITED: FDA inspection ending Feb 15, 2019
FDA inspection 1083851 · No Action Indicated (NAI) · Bengaluru
Key facts
| Inspection ID | 1083851 |
|---|---|
| Firm | BIOCON PHARMA LIMITED |
| FEI number | 3013637926 |
| Address | Special Economic Zone, Plot No.5 Phase Iv, Bommasandra - Jigani Link Rd, Bommasandra Post |
| City | Bengaluru |
| Fiscal year | 2019 |
| Inspection end date | Feb 15, 2019 |
| Classification | No Action Indicated (NAI) |
| Project area | Generic Drug Evaluation |
| Product type | Drugs |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data